{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T18:39:09Z","timestamp":1781116749851,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Science without Borders of CNPq","award":["200910\/2012-4"],"award-info":[{"award-number":["200910\/2012-4"]}]},{"DOI":"10.13039\/100005624","name":"PATH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005624","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005942","name":"Butantan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.vaccine.2017.01.030","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T22:30:14Z","timestamp":1486074614000},"page":"1306-1315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-0572","authenticated-orcid":false,"given":"Ivana B.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Herd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Moffitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Darrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana C.C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"87","key":"10.1016\/j.vaccine.2017.01.030_b0005","first-page":"129","article-title":"Pneumococcal vaccines. WHO position paper \u2013 2012","volume":"14","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.030_b0010","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/CMR.00024-15","article-title":"Pneumococcal capsules and their types: past, present, and future","volume":"28","author":"Geno","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2017.01.030_b0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein\u2013polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0020","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.01.030_b0025","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1016\/j.vaccine.2007.06.044","article-title":"WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26\u201327 October 2006, Geneva","volume":"25","author":"Cherian","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.030_b0030","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/IAI.69.8.4870-4873.2001","article-title":"Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci","volume":"69","author":"Malley","year":"2001","journal-title":"Infect Immun"},{"issue":"47","key":"10.1016\/j.vaccine.2017.01.030_b0035","doi-asserted-by":"crossref","first-page":"7468","DOI":"10.1016\/j.vaccine.2010.09.031","article-title":"GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis","volume":"28","author":"Lu","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.01.030_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000159","article-title":"Interleukin-17A mediates acquired immunity to pneumococcal colonization","volume":"4","author":"Lu","year":"2008","journal-title":"PLoS Pathog"},{"issue":"13","key":"10.1016\/j.vaccine.2017.01.030_b0045","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2017.01.030_b0050","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/315307","article-title":"Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease","volume":"181","author":"Vernacchio","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.030_b0055","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.4049\/jimmunol.170.12.6158","article-title":"Central role of complement in passive protection by human IgG1 and IgG2 anti-pneumococcal antibodies in mice","volume":"170","author":"Saeland","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0060","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1086\/529142","article-title":"Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory","volume":"46","author":"Roux","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.030_b0065","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.030_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/CVI.13.2.165-169.2006","article-title":"Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines","volume":"13","author":"Romero-Steiner","year":"2006","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.030_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CVI.00370-10","article-title":"Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera","volume":"18","author":"Rose","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0080","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cyto.2007.09.009","article-title":"Regulation of IL-17 production in human lymphocytes","volume":"41","author":"Chen","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2017.01.030_b0085","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.4049\/jimmunol.0802246","article-title":"IL-17 induces monocyte migration in rheumatoid arthritis","volume":"182","author":"Shahrara","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0090","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/eji.201141737","article-title":"Macrophages participate in IL-17-mediated inflammation","volume":"42","author":"Barin","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imbio.2012.02.007","article-title":"Mesenchymal stem cells promote neutrophil activation by inducing IL-17 production in CD4+ CD45RO+ T cells","volume":"218","author":"Hsu","year":"2013","journal-title":"Immunobiology"},{"issue":"4","key":"10.1016\/j.vaccine.2017.01.030_b0100","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1128\/IAI.74.4.2187-2195.2006","article-title":"Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide","volume":"74","author":"Malley","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.01.030_b0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.01.007","article-title":"Th17-based vaccine design for prevention of Streptococcus pneumoniae colonization","volume":"9","author":"Moffitt","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.030_b0110","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/CVI.00036-10","article-title":"Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine","volume":"17","author":"Lu","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2017.01.030_b0115","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s10295-008-0445-3","article-title":"Pneumococcal whole-cell vaccine: optimization of cell growth of unencapsulated Streptococcus pneumoniae in bioreactor using animal-free medium","volume":"35","author":"Liberman","year":"2008","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0120","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.vaccine.2013.10.091","article-title":"Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability","volume":"32","author":"Gon\u00e7alves","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2017.01.030_b0125","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.micinf.2008.01.007","article-title":"Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge","volume":"10","author":"Campos","year":"2008","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2017.01.030_b0130","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.vaccine.2010.12.074","article-title":"Selection of family 1 PspA molecules capable of inducing broad-ranging cross-reactivity by complement deposition and opsonophagocytosis by murine peritoneal cells","volume":"29","author":"Goulart","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.01.030_b0135","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj0940017","article-title":"The periodate oxidation of amino acids with reference to studies on glycoproteins","volume":"94","author":"Clamp","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.vaccine.2017.01.030_b0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1432-1033.1974.tb03671.x","article-title":"Proteinase K from Tritirachium album Limber","volume":"47","author":"Ebeling","year":"1974","journal-title":"Eur J Biochem"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.030_b0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1128\/IAI.72.1.114-122.2004","article-title":"Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface","volume":"72","author":"Ren","year":"2004","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.030_b0150","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1128\/CVI.00393-12","article-title":"The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro","volume":"19","author":"Ren","year":"2012","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.030_b0155","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/IAI.00881-09","article-title":"The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2017.01.030_b0160","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1128\/IAI.71.1.218-225.2003","article-title":"Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae","volume":"71","author":"Abeyta","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.030_b0165","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1128\/IAI.01186-08","article-title":"Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B","volume":"77","author":"Melin","year":"2009","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.030_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0026587","article-title":"Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence","volume":"6","author":"Sanchez","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.030_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0059605","article-title":"Characterization of protective immune responses induced by pneumococcal surface protein A in fusion with pneumolysin derivatives","volume":"8","author":"Goulart","year":"2013","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2017.01.030_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000476","article-title":"Pneumococcal capsular polysaccharide structure predicts serotype prevalence","volume":"5","author":"Weinberger","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.01.030_b0185","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1172\/JCI110444","article-title":"A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia","volume":"69","author":"Brown","year":"1982","journal-title":"J Clin Invest"},{"issue":"46","key":"10.1016\/j.vaccine.2017.01.030_b0190","doi-asserted-by":"crossref","first-page":"8241","DOI":"10.1016\/j.vaccine.2011.08.119","article-title":"The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis","volume":"29","author":"Ricci","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.030_b0195","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/IAI.01056-09","article-title":"Streptococcus pneumoniae capsule resistance to complement-mediated immunity is dependent on the capsular serotype","volume":"78","author":"Hyams","year":"2010","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2017.01.030_b0200","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/IAI.00740-10","article-title":"The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement","volume":"78","author":"Melin","year":"2010","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2017.01.030_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0024581","article-title":"Effects of Streptococcus pneumoniae strain background on complement resistance","volume":"6","author":"Hyams","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.030_b0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0882-4010(90)90091-4","article-title":"Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods","volume":"8","author":"Sorensen","year":"1990","journal-title":"Microb Pathog"},{"issue":"13","key":"10.1016\/j.vaccine.2017.01.030_b0215","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1128\/JB.187.13.4470-4479.2005","article-title":"Initiation and synthesis of the Streptococcus pneumoniae type 3 capsule on a phosphatidylglycerol membrane anchor","volume":"187","author":"Cartee","year":"2005","journal-title":"J Bacteriol"},{"issue":"2","key":"10.1016\/j.vaccine.2017.01.030_b0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1128\/CVI.00591-15","article-title":"Capsular polysaccharide (CPS) release by serotype 3 pneumococcal strains reduces the protective effect of anti-type 3 CPS antibodies","volume":"23","author":"Choi","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0225","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1086\/597425","article-title":"A 28-aa pneumococcal surface adhesin A\u2013derived peptide, P4, augments passive immunotherapy and rescues mice from fatal pneumococcal infection","volume":"199","author":"Rajam","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.01.030_b0230","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2017.01.030_b0235","article-title":"Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection","author":"Wang","year":"2016","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17300798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T16:41:58Z","timestamp":1601570518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17300798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0264410X17300798"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}